These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7128917)

  • 1. Importance of the alkylaminoethoxy side-chain for the estrogenic and antiestrogenic actions of tamoxifen and trioxifene in the immature rat uterus.
    Jordan VC; Gosden B
    Mol Cell Endocrinol; 1982 Aug; 27(3):291-306. PubMed ID: 7128917
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential antiestrogen action in the immature rat uterus: a comparison of hydroxylated antiestrogens with high affinity for the estrogen receptor.
    Jordan VC; Gosden B
    J Steroid Biochem; 1983 Sep; 19(3):1249-58. PubMed ID: 6684713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen.
    Löser R; Seibel K; Roos W; Eppenberger U
    Eur J Cancer Clin Oncol; 1985 Aug; 21(8):985-90. PubMed ID: 4043181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing biological actions of antiestrogens in vitro and in vivo: induction of progesterone receptor in the rat and mouse uterus.
    Campen CA; Jordan VC; Gorski J
    Endocrinology; 1985 Jun; 116(6):2327-36. PubMed ID: 3996316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the uterotropic activity of estrogens and antiestrogens by the short acting antiestrogen LY117018.
    Jordan VC; Gosden B
    Endocrinology; 1983 Aug; 113(2):463-8. PubMed ID: 6872937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
    Wakeling AE; Valcaccia B
    J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of daily anti-estrogen treatment on uterine growth and progesterone receptor concentrations in adult rat uterus.
    Janssens JP; Billiet G; Bonte J; De Loecker W
    Anticancer Res; 1984; 4(3):157-62. PubMed ID: 6465854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice.
    Black LJ; Goode RL
    Life Sci; 1980 Apr; 26(17):1453-8. PubMed ID: 7382727
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for biological action of the antiestrogens LY117018 and tamoxifen by different mechanisms.
    Black LJ; Goode RL
    Endocrinology; 1981 Sep; 109(3):987-9. PubMed ID: 7262030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus.
    Wakeling AE; O'Connor KM; Newboult E
    J Endocrinol; 1983 Dec; 99(3):447-53. PubMed ID: 6644235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative differences in estrogenic/antiestrogenic effects of clomiphene and zuclomiphene.
    Young RL; Goldzieher JW; Chakraborty PK; Panko WB; Bridges CN
    Int J Fertil; 1991; 36(5):291-5. PubMed ID: 1683658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of rat uterine progesterone receptor levels and peroxidase activity by tamoxifen citrate, LY117018, and estradiol.
    Keeping HS; Lyttle CR
    Endocrinology; 1982 Dec; 111(6):2046-54. PubMed ID: 6890442
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential interaction of antiestrogens with cytosol estrogen receptors.
    Black LJ; Jones CD; Goode RL
    Mol Cell Endocrinol; 1981 Apr; 22(1):95-103. PubMed ID: 7239000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiestrogenic and antitumor properties of the new triphenylethylene derivative toremifene in the rat.
    di Salle E; Zaccheo T; Ornati G
    J Steroid Biochem; 1990 Jun; 36(3):203-6. PubMed ID: 2142233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
    Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
    Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkyl polychlorinated dibenzofurans and related compounds as antiestrogens in the female rat uterus: structure-activity studies.
    Dickerson R; Keller LH; Safe S
    Toxicol Appl Pharmacol; 1995 Dec; 135(2):287-98. PubMed ID: 8545839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-Carbamoylalkyl-2-phenylindoles: relationship between side chain structure and estrogen antagonism.
    von Angerer E; Biberger C; Holler E; Koop R; Leichtl S
    J Steroid Biochem Mol Biol; 1994 May; 49(1):51-62. PubMed ID: 8003439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of 6-nitro-1,3,8-trichlorodibenzofuran as a partial estrogen in the female rat uterus.
    Dickerson R; Howie L; Safe S
    Toxicol Appl Pharmacol; 1992 Mar; 113(1):55-63. PubMed ID: 1313194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-stimulated growth of human endometrial carcinoma.
    Jordan VC; Gottardis MM; Satyaswaroop PG
    Ann N Y Acad Sci; 1991; 622():439-46. PubMed ID: 1905895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.